UBS(Lux)E.F.-S.Health Tr.(USD)P CHF H/ LU2402148493 /
NAV03/10/2024 | Chg.-0.7500 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
99.7900CHF | -0.75% | reinvestment | Equity Worldwide | UBS AM S.A. (EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | - | - | - | - | - | - | - | - | - | - | - | 6.16 | - |
2022 | -9.52 | 0.97 | 4.38 | -5.50 | -1.73 | -0.79 | 3.60 | -7.07 | -5.47 | 4.68 | 5.92 | -2.12 | -13.22% |
2023 | -0.41 | -4.20 | 1.44 | 5.06 | -4.16 | 4.32 | 1.85 | -2.10 | -3.24 | -6.10 | 6.48 | 6.21 | +4.17% |
2024 | -1.60 | 1.27 | 1.82 | -3.28 | 3.87 | 0.97 | 5.11 | 2.44 | -2.71 | -1.46 | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 11.39% | 11.01% | 11.97% | -% | -% |
Sharpe ratio | 0.45 | 1.19 | 0.96 | - | - |
Best month | +6.21% | +5.11% | +6.48% | +6.48% | - |
Worst month | -3.28% | -3.28% | -6.10% | -9.52% | - |
Maximum loss | -7.51% | -4.19% | -7.52% | - | - |
Outperformance | - | - | - | - | - |
All quotes in CHF
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
UBS (Lux) Equity Fund - Sustaina... | reinvestment | 288.0500 | +21.00% | +17.00% | |
UBS(Lux)E.F.-S.Health Tr.(USD)P ... | reinvestment | 104.2200 | +17.74% | - | |
UBS(Lux)E.F.-S.Health Tr.(USD)F ... | reinvestment | 121.6000 | +21.36% | - | |
UBS(Lux)E.F.-S.Health Tr.(USD)P ... | reinvestment | 99.7900 | +14.78% | - | |
UBS(Lux)E.F.-S.Health Tr.(USD)Q ... | reinvestment | 102.1100 | +15.69% | - | |
UBS(Lux)E.F.-S.Health Tr.(USD)Q ... | reinvestment | 106.6500 | +18.67% | - | |
UBS (Lux) Equity Fund - Sustaina... | reinvestment | 459.7800 | +20.03% | +14.22% |
Performance
YTD | +6.24% | ||
---|---|---|---|
6 Months | +7.88% | ||
1 Year | +14.78% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - | ||
Since start | +0.52% | ||
Year | |||
2023 | +4.17% | ||
2022 | -13.22% |